Saturday, July 11, 2026

pharma · Hypertension

Innovent Biologics

Innovent Biologics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Suzhou, CN HQ
2011 Founded
850 Employees
NMPA registrant Type
Company details
Intelligence · Clinical Programs

Innovent Biologics projects

2 ClinicalTrials.gov programs sponsored by Innovent Biologics.

Innovent Biologics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. IBI3016

    Innovent Biologics (Suzhou) Co.

    Hypertension

    phase 2 small molecule active

    2 trials
  2. placebo

    Innovent Biologics (Suzhou) Co.

    Healthy

    phase 1 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Innovent Biologics have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.